SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-014171
Filing Date
2018-02-27
Accepted
2018-02-27 18:30:46
Documents
2
Period of Report
2018-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1597
2 POA DOCUMENT poa.txt EX-24.3_773100 3933
  Complete submission text file 0001209191-18-014171.txt   6954
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CLEARSIDE BIOMEDICAL, INC. 1220 OLD ALPHARETTA ROAD, SUITE 300 ALPHARETTA GA 30005
Business Address
Raymond Brion S. (Reporting) CIK: 0001732744 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 18647146